Replication study of STAT4 rs7574865 G/T polymorphism and risk of rheumatoid arthritis in a Chinese population

Gene

Volumn 526, Issue 2, 2013, Pages 259-264

  Shen, Li ^a   Liu, Ruiping ^b   Zhang, Hui ^b   Huang, Yong ^b   Sun, Rongbin ^b   Tang, Peifu ^c  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Ankylosing spondylitis; Molecular epidemiology; Polymorphisms; Rheumatoid arthritis; STAT4

Indexed keywords

STAT4 PROTEIN;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY SCORE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; REPLICATION STUDY; RHEUMATOID ARTHRITIS; TIME OF FLIGHT MASS SPECTROMETRY;

ANKYLOSING SPONDYLITIS; CI; CONFIDENCE INTERVAL; LD; LINKAGE DISEQUILIBRIUM; MOLECULAR EPIDEMIOLOGY; ODDS RATIO; OR; POLYMORPHISMS; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 4; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; STAT4;

ADULT; AGED; ALLELES; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SPONDYLITIS, ANKYLOSING; STAT4 TRANSCRIPTION FACTOR; YOUNG ADULT;

EID: 84880753140     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.05.022     Document Type: Article

References (24)

1. Abelson A.K., et al. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann. Rheum. Dis. 2009, 68:1746-1753.
2. Arnett F.C., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31:315-324.
3. Becker K.G. The common variants/multiple disease hypothesis of common complex genetic disorders. Med. Hypotheses 2004, 62:309-317.
4. Braun J., Sieper J. Ankylosing spondylitis. Lancet 2007, 369:1379-1390.
5. Cheng J., Zhang H., Zhuang C., Liu R. Peptidylarginine deiminase type 4 and methyl-CpG binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis. J. Rheumatol. 2012, 39:1159-1165.
6. Fernando M.M., et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet. 2008, 4:e1000024.
7. Finnegan A., et al. IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms. J. Immunol. 2002, 169:3345-3352.
8. FitzGerald O., Soden M., Yanni G., Robinson R., Bresnihan B. Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann. Rheum. Dis. 1991, 50:792-796.
9. Frucht D.M., et al. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J. Immunol. 2000, 164:4659-4664.
10. Gregersen P.K., Behrens T.W. Genetics of autoimmune diseases-disorders of immune homeostasis. Nat. Rev. Genet. 2006, 7:917-928.
11. Hildner K.M., et al. Targeting of the transcription factor STAT4 by antisense phosphorothioate oligonucleotides suppresses collagen-induced arthritis. J. Immunol. 2007, 178:3427-3436.
12. Iguchi T., Ziff M. Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J. Clin. Invest. 1986, 77:355-361.
13. Kaplan M.H. STAT4: a critical regulator of inflammation in vivo. Immunol. Res. 2005, 31:231-242.
14. Korman B.D., Kastner D.L., Gregersen P.K., Remmers E.F. STAT4: genetics, mechanisms, and implications for autoimmunity. Curr. Allergy Asthma Rep. 2008, 8:398-403.
15. Liang Y.L., et al. Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis. Mol. Biol. Rep. 2012, 39:8873-8882.
16. Mathur A.N., et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J. Immunol. 2007, 178:4901-4907.
17. Miossec P. Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified. Arthritis Rheum. 2007, 56:2111-2115.
18. Remmers E.F., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 2007, 357:977-986.
19. Sigurdsson S., et al. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Hum. Mol. Genet. 2008, 17:2868-2876.
20. Stamm L.M., Satoskar A.A., Ghosh S.K., David J.R., Satoskar A.R. STAT-4 mediated IL-12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis. Eur. J. Immunol. 1999, 29:2524-2529.
21. van der Heijde D., Calin A., Dougados M., Khan M.A., van der Linden S., Bellamy N. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS working group. Assessments in ankylosing spondylitis. J. Rheumatol. 1999, 26:951-954.
22. van der Linden S., Valkenburg H.A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27:361-368.
23. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 2004, 202:139-156.
24. Zervou M.I., et al. Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population. Hum. Immunol. 2008, 69:567-571.